AstraZeneca cuts UK investment after government reduces site expansion support; Viking secures API supply; Jabil acquires ...

Open source messaging tools find a home in .NET distributed applications. NATS makes it easier for the messages of at-scale ...

The 3x15 system the global Badminton body is ready to implement is expected to create more exciting and close matches.

Cendakimab fell short of the bar. The antibody hits IL-13, one of the interleukins targeted by Regeneron and Sanofi’s ...

The partnership between the US military and the body and the non-profit will examine three drugs as potential therapies ...

Novo Nordisk has bolstered the case for its near-approval hemophilia A drug candidate Mim8, linking the prospect to ...

Good day, everyone, and welcome to today's Neurocrine Biosciences reports Q4 and fiscal year 2024 Earnings Call. (Operator Instructions) Please note today's call will be recorded and I will be ...

AstraZeneca has terminated all development of vemircopan, the oral factor D inhibitor it acquired through the deal for ...

OpenAI on Thursday launched data residency in Europe, allowing European organizations to meet local data sovereignty ...

Shares of GH Research PLC GHRS have rallied 54.8% in a week after the company, on Feb. 3, 2025, announced that it has met the ...

Vaxcyte has advanced to the Phase II trial’s second and final stage (Stage 2) assessing its 31-valent pneumococcal conjugate ...

We recently compiled a list of the Jim Cramer Highlighted Buying Opportunities in 13 Stocks. In this article, we are going to ...